文献速递甲状腺疾病

瑞典分化型甲状腺癌患者全甲状腺切除与放射性碘治疗后的健康相关生活质量五年随访:一项全国性前瞻性队列研究

Five-Year Follow-Up of Health-Related Quality of Life in Differentiated Thyroid Cancer Patients Treated with Total Thyroidectomy and Radioiodine in Sweden: A Nationwide Prospective Cohort Study.
PubMed 文献 · Thyroid · 2024-04-05

该全国性前瞻性队列研究纳入2012至2017年瑞典收治的487例分化型甲状腺癌患者,其中351例同意参与,在接受全甲状腺切除并计划放射性碘治疗时及治疗后1、3、5年填写SF-36问卷。结果显示躯体生活质量无显著变化,心理生活质量平均每年改善0.61(p<0.001),TSH水平不能预测生活质量或其变化;5年时与瑞典一般人群相比躯体与心理生活质量差异效应量小,但一般健康、活力、社会功能与心理健康等维度评分较低(差异8.7-13.3)且具临床意义。

要点

  • 分化型甲状腺癌治疗后5年内心理生活质量平均每年改善0.61(p<0.001),躯体生活质量无显著变化。
  • TSH抑制水平不能预测躯体或心理生活质量及其随时间的变化。
  • 5年时一般健康、活力、社会功能与心理健康维度低于一般人群(差异8.7-13.3),具临床意义。

核心结论

  • 分化型甲状腺癌治疗后健康相关生活质量的心理组分随时间改善,而躯体组分无显著变化。
  • 分化型甲状腺癌患者的生活质量不能由TSH抑制解释。
  • 尽管5年时与一般人群的总体躯体与心理生活质量差异较小,但若干特定心理社会生活质量维度存在有临床意义的降低,作者建议在分化型甲状腺癌随访中筛查心理社会健康问题。

研究设计与样本

  • 全国性前瞻性队列研究,2012至2017年从瑞典所有收治分化型甲状腺癌患者的医院识别487例患者。
  • 患者接受全甲状腺切除并计划放射性碘治疗,采用瑞典版SF-36健康调查简表及研究特定问卷在治疗时及治疗后1、3、5年评估。
  • 共351例患者同意参与;采用线性混合模型对多重插补数据进行分析,模型纳入所有患者及测量时间点。

主要发现

  • 治疗后5年内躯体生活质量随时间无显著变化,心理生活质量平均每年改善0.61(p<0.001)。
  • TSH水平不能预测躯体或心理生活质量,也不能预测其随时间的变化。
  • 5年时与瑞典一般人群相比躯体与心理生活质量差异显著,但效应量小(Cohen's d分别为0.29和-0.21)。
  • 5年时SF-36一般健康、活力、社会功能与心理健康维度低于一般人群(差异8.7-13.3),且这些差异具临床意义。

临床怎么用

  • 作者认为,分化型甲状腺癌随访期间应筛查心理社会健康问题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Despite a good prognosis, survivors of differentiated thyroid cancer (DTC) may have reduced health-related quality of life (HRQOL) many years after treatment, and it is unclear how suppression of thyroid-stimulating hormone (TSH) may contribute to HRQOL. This study investigated changes in HRQOL in the 5 years following DTC treatment, the association between HRQOL and TSH suppression, and how HRQOL compares to the general population. Methods: In this nationwide prospective cohort study, 487 patients with DTC were identified between 2012 and 2017 from all Swedish hospitals treating patients with DTC. Patients treated with total thyroidectomy and planned for radioiodine answered the Swedish version of the Short Form-36 Health Survey (SF-36) and a study specific questionnaire at treatment and after 1, 3, and 5 years. Summary measures for physical and mental QOL were derived from the SF-36, and TSH values were collected from patient records. To study changes in HRQOL over time, linear mixed models were fitted on multiply imputed data, with all patients and measurement points included in the model. Results: In total, 351 patients consented to participate in the study. In the 5 years following DTC treatment, physical QOL did not change significantly with time, while mental QOL improved by on average 0.61 (p < 0.001) per year. TSH levels were not predictive of either physical or mental QOL, or their change over time. At 5 years, there was a significant difference in physical and mental QOL compared with the Swedish general population, but effect sizes were small (Cohen's d = 0.29 and -0.21, respectively). The SF-36 domains general health, vitality, social functioning, and mental health were lower at 5 years compared with the general population (difference 8.7-13.3), and these differences were clinically significant. Conclusions: The mental component of HRQOL improves over time following DTC treatment. HRQOL in patients with DTC is not explained by TSH suppression. Although overall differences in physical and mental HRQOL compared with the general population were small 5 years after treatment, several specific psychosocial HRQOL domains were clinically meaningfully reduced. Psychosocial health issues should be screened for during DTC follow-up.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Winter J, Axelsson E, Björkhem-Bergman L, et al. Five-Year Follow-Up of Health-Related Quality of Life in Differentiated Thyroid Cancer Patients Treated with Total Thyroidectomy and Radioiodine in Sweden: A Nationwide Prospective Cohort Study. Thyroid. 2024. PMID: 38526369. doi:10.1089/thy.2023.0691

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。